Multiple Myeloma an incurable disease, but I have spent the last 25 years in remission using a blend of conventional oncology and evidence-based nutrition, supplementation, and lifestyle therapies from peer-reviewed studies that your oncologist probably hasn't told you about.
Click the orange button to the right to learn more about what you can start doing today.
Chemotherapy-induced peripheral neuropathy is a common side effect of several different chemotherapy regimens and as a short or long-term side effect it can be remarkably painful.
Though I do not suffer from chemotherapy-induced peripheral neuropathy, I do manage several side effects of my conventional cancer therapies and I have had weekly acupuncture treatments for two years now.
So when I come across a study that examines a side effects and therapy that can affect many, many myeloma survivors, I just at the change to write about it.
What is acupuncture? How does it work?
What side effects from cancer treatment are treated with acupuncture?
Chemotherapy-induced peripheral neuropathy is a serious side effect. Conventional oncology offers no therapies that work consistently.
Email me at David.PeopleBeatingCancer@gmail.com with questions about any treatment related side effects.
Thank you,
“Background: Chemotherapy-induced peripheral neuropathy (CIPN) is one of the commonly reported symptoms impacting cancer survivors. This study evaluated and compared the effectiveness of acupuncture treatments for CIPN.
Methods: We searched six databases from their inception to August 2024 to identify eligible randomized controlled trials (RCTs). Primary outcomes were pain scores. Secondary outcomes were quality of life including FACT/GOG-Ntx and EORTC QLQ-C30. The robust error meta-regression (REMR) method was used to evaluate the dose-response relationship across treatment parameters, including number of sessions, frequency, and duration.
Results: In total, 11 RCTs featuring 740 participants were included. The meta-analysis demonstrated that the primary analysis achieved a significant reduction in pain scores, with a standardized mean difference of [SMD= -1.23, 95% CI = (-2.22, -0.24); P < 0.01; I² = 95%], improvement quality of life including FACT/GOG-Ntx [SMD = 0.95, 95% CI = (0.02, 1.88); P < 0.01; I² = 93%] and EORTC QLQ-C30 [SMD = 0.36, 95% CI = (0.03, 0.68); P = 0.14; I² = 46%].
The nonlinear dose-response analysis suggests that pain improvement achieves the MCID at 16 treatment sessions, over 8 weeks, with a frequency of twice per week.
Furthermore, analysis of the treatment duration chart shows that acupuncture maintains therapeutic effects during the follow-up period. Sensitivity analysis confirmed the robustness of these findings…”
“Introduction-
Chemotherapy-induced peripheral neuropathy (CIPN) is a serious potential side effect of treatment with a number of chemotherapeutic agents, including taxanes, platinum-based compounds, vinca alkaloids, epothilones, and bortezomib, and CIPN affects between 30 to 40% of patients treated with these agents [1, 2]. Symptoms of CIPN result from damage to dorsal root ganglion neurons or their axons, leading to physical findings of a sensory peripheral neuropathy including sensory loss, paresthesia, ataxia, and allodynia [2, 3]. Nerve conduction studies in patients with CIPN show that both small and large motor and sensory nerve fibers undergo axonal degeneration, leading to these often debilitating symptoms [4]…
Cryotherapy and compression therapy
Cryotherapy involves cooling the skin surface in an attempt to limit local effects of chemotherapy. This can involve limb-induced hypothermia or cooling gloves or socks, and it is often combined with compression therapy, a process that utilizes elastic stockings or surgical gloves to apply diffuse pressure to the skin surface [82].
Used for the prevention of CIPN, prophylactic cryotherapy has been shown to reduce the risk of dose reduction of taxane-based chemotherapy [83]. Additional studies have sought to determine its ability to prevent CIPN symptoms.
Compression therapy can be used with or without cryotherapy for prevention of CIPN, although it is much less expensive than cryotherapy when used alone. Prospective and phase II trials have shown the benefit of cryotherapy in preventing peripheral neuropathy in patients undergoing neurotoxic chemotherapy [84, 85], although it should be noted that studies of cryotherapy and compression therapy showed that compression therapy alone appears to be just as effective as cryotherapy [82].
All of these studies were limited by sample size and warrant further investigation with multi-institution, randomized controlled trials in the future. These studies are currently under development…”